







Looking Back and Current Viewpoint of U.S. Domestic Production of Medical PPE
The Supply Chain Matters blog provides a look back and current viewpoint of efforts to encourage a U.S. domestic production capability of medical PPE. Based on one domestic supplier’s perspective, optimism still prevails especially around more educated and more risk aware healthcare procurement teams

Supply Chain Matters Global Supply Chain News Capsule Follow-Up- June 12 2021
The Supply Chain Matters blog provides an updated capsule of noteworthy updates to prior global supply chain news developments that we have previously highlighted for our readers. In this update, we update developments related to the distribution of the Johnson and Johnson COVID-19 vaccine, and in Airbus efforts to renew monthly manufacturing volumes.

Supply Chain Matters Global Supply News Capsule Follow-Up
The Supply Chain Matters blog provides a capsule of noteworthy updates to prior global supply chain news developments. Included companies and developments in this update are Johnson and Johnson, Canadian National and Kansas City Southern Railroad, railroad, Blue Yonder and Kinaxis, and the initial legal trade disputes related to the USMCA trade agreement.


The Johnson & Johnson Vaccine Production Mix-up- The Message of Stepped-Up Quality Monitoring and Controls
The Supply Chain Matters blog provides commentary on last week’s revelation of a COVID-19 vaccine production facility’s snafu in producing the Johnson & Johnson vaccine. The commentary addresses what mitigation actions the industry needs to undertake to insure the quality needs of COVID-19 vaccines produced at such volumes.
